# Emerge Life Sciences

Emerge Life Sciences is a Private Equity based in Singapore, Singapore.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Singapore, Singapore
- **Region:** Asia
- **Address:** Singapore, Singapore
- **Founded:** 2013
- **Assets under management:** Undisclosed
- **Website:** www.emergeout.com

## Regulatory record

- **Reports private funds:** No

## About

Emerge Life Sciences is a private equity firm based in Singapore. It focuses on a Venture Capital strategy. The firm has a team of four staff, including four investment professionals.

## Sectors

- Digital Health
- Healthcare Services

## Questions

### Which sectors does Emerge Life Sciences invest in?

The firm invests across the life sciences spectrum, including therapeutics, diagnostics, medical devices, and digital health platforms. Its mandate encompasses biopharma companies developing novel drug candidates, medtech startups building diagnostic or surgical tools, and healthtech platforms applying software to care delivery and clinical workflows. The breadth allows the firm to evaluate opportunities wherever biology and technology intersect.

### Does Emerge Life Sciences invest only in Asia-based companies?

While Emerge Life Sciences is headquartered in Singapore and carries a strong Asia origination focus, it maintains a global investment lens. The firm can invest in companies outside Asia when the scientific opportunity warrants, particularly in markets where Asian-based investors can add strategic value for companies seeking to enter Asia-Pacific healthcare markets. Specific geographic allocations have not been publicly disclosed.

### Is Emerge Life Sciences a venture capital firm or a private equity firm?

Emerge Life Sciences is structured as a private equity firm, but its early-stage focus aligns it more closely with venture capital in operational practice. The firm makes minority equity investments in start-up life sciences companies rather than pursuing later-stage buyouts. The firm identifies as a private equity manager, a classification that often reflects its regulatory and fundraising infrastructure rather than a departure from venture-stage investing.

### Who runs investment decisions at Emerge Life Sciences?

Specific principals and investment committee members at Emerge Life Sciences have not been publicly identified. The firm does not currently detail its leadership team, investment professionals, or governance structure on its official website or publicly available business registries. This limited disclosure is not uncommon among small and early-stage investment managers in Asia, but it means allocators conducting diligence will need to engage the firm directly to assess team composition, relevant scientific backgrounds, and decision-making authority.

## Related profiles

- [Emerge Education](https://altss.com/profile/emerge-education)
- [Emergence Capital](https://altss.com/profile/emergence-capital-partners)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/emerge-life-sciences

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology